CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 97 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,325,000 | -10.3% | 150,000 | 0.0% | 0.14% | -15.7% |
| Q1 2017 | $2,591,000 | +57.1% | 150,000 | 0.0% | 0.17% | +60.7% |
| Q4 2016 | $1,649,000 | -29.9% | 150,000 | 0.0% | 0.11% | -25.7% |
| Q3 2016 | $2,352,000 | +53.5% | 150,000 | 0.0% | 0.14% | +53.2% |
| Q2 2016 | $1,532,000 | -20.8% | 150,000 | 0.0% | 0.09% | -13.0% |
| Q1 2016 | $1,935,000 | -7.3% | 150,000 | +50.0% | 0.11% | +3.8% |
| Q4 2015 | $2,087,000 | – | 100,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $43,106,000 | 1.62% |
| Altium Capital Management LP | 483,041 | $3,734,000 | 1.04% |
| RA Capital Management | 3,500,000 | $27,055,000 | 0.41% |
| Point72 Asset Management, L.P. | 6,335,000 | $48,970,000 | 0.23% |
| Perceptive Advisors | 2,153,974 | $16,650,000 | 0.21% |
| RTW INVESTMENTS, LP | 1,533,758 | $11,856,000 | 0.18% |
| GLOBEFLEX CAPITAL L P | 115,647 | $894,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 785,899 | $6,075,000 | 0.14% |
| Affinity Asset Advisors, LLC | 50,000 | $387,000 | 0.13% |
| Virtus ETF Advisers LLC | 38,021 | $294,000 | 0.12% |